Selected research
Industry Research
TYK2 Targeting Drugs Industry Research Report 2026
Market perspective
The global TYK2 Targeting Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for TYK2 Targeting Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for TYK2 Targeting Drugs is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for TYK2 Targeting Drugs is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of TYK2 Targeting Drugs include Inventisbio, Qiyuan Biotechnology, InnoCare, Guangzhou Zaiji Pharmaceutical, Changzhou Hengbang Pharmaceutical, BeiGene, Ventyx Biosciences, Takeda (Nimbus Therapeutics) and Sareum Holdings Pic, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global TYK2 Targeting Drugs market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
TYK2 Targeting Drugs Market by Company
Inventisbio
Qiyuan Biotechnology
InnoCare
Guangzhou Zaiji Pharmaceutical
Changzhou Hengbang Pharmaceutical
BeiGene
Ventyx Biosciences
Takeda (Nimbus Therapeutics)
Sareum Holdings Pic
Oncostellae
Galapagos NV
Bristol Myers Squibb
TYK2 Targeting Drugs Segment by Type
Single-target Inhibitors
Dual-target Inhibitors
TYK2 Targeting Drugs Segment by Application
Psoriasis
Systemic Lupus Erythematosus
Dermatitis
Arthritis
Others
TYK2 Targeting Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global TYK2 Targeting Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of TYK2 Targeting Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of TYK2 Targeting Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of TYK2 Targeting Drugs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of TYK2 Targeting Drugs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of TYK2 Targeting Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Single-target Inhibitors
- Dual-target Inhibitors
Applications
- Psoriasis
- Systemic Lupus Erythematosus
- Dermatitis
- Arthritis
- Others
Companies covered
- Inventisbio
- Qiyuan Biotechnology
- InnoCare
- Guangzhou Zaiji Pharmaceutical
- Changzhou Hengbang Pharmaceutical
- BeiGene
- Ventyx Biosciences
- Takeda (Nimbus Therapeutics)
- Sareum Holdings Pic
- Oncostellae
- Galapagos NV
- Bristol Myers Squibb
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global TYK2 Targeting Drugs Market Size (2021-2032)
- 2.2.2 Global TYK2 Targeting Drugs Sales (2021-2032)
- 2.2.3 Global TYK2 Targeting Drugs Market Average Price (2021-2032)
- 2.3 TYK2 Targeting Drugs by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Single-target Inhibitors
- 2.3.3 Dual-target Inhibitors
- 2.4 TYK2 Targeting Drugs by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Psoriasis
- 2.4.3 Systemic Lupus Erythematosus
- 2.4.4 Dermatitis
- 2.4.5 Arthritis
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global TYK2 Targeting Drugs Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global TYK2 Targeting Drugs Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global TYK2 Targeting Drugs Revenue of Manufacturers (2021-2026)
- 3.4 Global TYK2 Targeting Drugs Average Price by Manufacturers (2021-2026)
- 3.5 Global TYK2 Targeting Drugs Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of TYK2 Targeting Drugs, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of TYK2 Targeting Drugs, Product Type & Application
- 3.8 Global Manufacturers of TYK2 Targeting Drugs, Established Date
- 3.9 Global TYK2 Targeting Drugs Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Inventisbio
- 4.1.1 Inventisbio Company Information
- 4.1.2 Inventisbio Business Overview
- 4.1.3 Inventisbio TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Inventisbio TYK2 Targeting Drugs Product Portfolio
- 4.1.5 Inventisbio Recent Developments
- 4.2 Qiyuan Biotechnology
- 4.2.1 Qiyuan Biotechnology Company Information
- 4.2.2 Qiyuan Biotechnology Business Overview
- 4.2.3 Qiyuan Biotechnology TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Qiyuan Biotechnology TYK2 Targeting Drugs Product Portfolio
- 4.2.5 Qiyuan Biotechnology Recent Developments
- 4.3 InnoCare
- 4.3.1 InnoCare Company Information
- 4.3.2 InnoCare Business Overview
- 4.3.3 InnoCare TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 InnoCare TYK2 Targeting Drugs Product Portfolio
- 4.3.5 InnoCare Recent Developments
- 4.4 Guangzhou Zaiji Pharmaceutical
- 4.4.1 Guangzhou Zaiji Pharmaceutical Company Information
- 4.4.2 Guangzhou Zaiji Pharmaceutical Business Overview
- 4.4.3 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Guangzhou Zaiji Pharmaceutical TYK2 Targeting Drugs Product Portfolio
- 4.4.5 Guangzhou Zaiji Pharmaceutical Recent Developments
- 4.5 Changzhou Hengbang Pharmaceutical
- 4.5.1 Changzhou Hengbang Pharmaceutical Company Information
- 4.5.2 Changzhou Hengbang Pharmaceutical Business Overview
- 4.5.3 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Changzhou Hengbang Pharmaceutical TYK2 Targeting Drugs Product Portfolio
- 4.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
- 4.6 BeiGene
- 4.6.1 BeiGene Company Information
- 4.6.2 BeiGene Business Overview
- 4.6.3 BeiGene TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 BeiGene TYK2 Targeting Drugs Product Portfolio
- 4.6.5 BeiGene Recent Developments
- 4.7 Ventyx Biosciences
- 4.7.1 Ventyx Biosciences Company Information
- 4.7.2 Ventyx Biosciences Business Overview
- 4.7.3 Ventyx Biosciences TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Ventyx Biosciences TYK2 Targeting Drugs Product Portfolio
- 4.7.5 Ventyx Biosciences Recent Developments
- 4.8 Takeda (Nimbus Therapeutics)
- 4.8.1 Takeda (Nimbus Therapeutics) Company Information
- 4.8.2 Takeda (Nimbus Therapeutics) Business Overview
- 4.8.3 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Takeda (Nimbus Therapeutics) TYK2 Targeting Drugs Product Portfolio
- 4.8.5 Takeda (Nimbus Therapeutics) Recent Developments
- 4.9 Sareum Holdings Pic
- 4.9.1 Sareum Holdings Pic Company Information
- 4.9.2 Sareum Holdings Pic Business Overview
- 4.9.3 Sareum Holdings Pic TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sareum Holdings Pic TYK2 Targeting Drugs Product Portfolio
- 4.9.5 Sareum Holdings Pic Recent Developments
- 4.10 Oncostellae
- 4.10.1 Oncostellae Company Information
- 4.10.2 Oncostellae Business Overview
- 4.10.3 Oncostellae TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Oncostellae TYK2 Targeting Drugs Product Portfolio
- 4.10.5 Oncostellae Recent Developments
- 4.11 Galapagos NV
- 4.11.1 Galapagos NV Company Information
- 4.11.2 Galapagos NV Business Overview
- 4.11.3 Galapagos NV TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Galapagos NV TYK2 Targeting Drugs Product Portfolio
- 4.11.5 Galapagos NV Recent Developments
- 4.12 Bristol Myers Squibb
- 4.12.1 Bristol Myers Squibb Company Information
- 4.12.2 Bristol Myers Squibb Business Overview
- 4.12.3 Bristol Myers Squibb TYK2 Targeting Drugs Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Bristol Myers Squibb TYK2 Targeting Drugs Product Portfolio
- 4.12.5 Bristol Myers Squibb Recent Developments
5 Global TYK2 Targeting Drugs Market Scenario by Region
- 5.1 Global TYK2 Targeting Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global TYK2 Targeting Drugs Sales by Region: 2021-2032
- 5.2.1 Global TYK2 Targeting Drugs Sales by Region: 2021-2026
- 5.2.2 Global TYK2 Targeting Drugs Sales by Region: 2027-2032
- 5.3 Global TYK2 Targeting Drugs Revenue by Region: 2021-2032
- 5.3.1 Global TYK2 Targeting Drugs Revenue by Region: 2021-2026
- 5.3.2 Global TYK2 Targeting Drugs Revenue by Region: 2027-2032
- 5.4 North America TYK2 Targeting Drugs Market Facts & Figures by Country
- 5.4.1 North America TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America TYK2 Targeting Drugs Sales by Country (2021-2032)
- 5.4.3 North America TYK2 Targeting Drugs Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe TYK2 Targeting Drugs Market Facts & Figures by Country
- 5.5.1 Europe TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe TYK2 Targeting Drugs Sales by Country (2021-2032)
- 5.5.3 Europe TYK2 Targeting Drugs Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific TYK2 Targeting Drugs Market Facts & Figures by Country
- 5.6.1 Asia Pacific TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific TYK2 Targeting Drugs Sales by Country (2021-2032)
- 5.6.3 Asia Pacific TYK2 Targeting Drugs Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America TYK2 Targeting Drugs Market Facts & Figures by Country
- 5.7.1 South America TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America TYK2 Targeting Drugs Sales by Country (2021-2032)
- 5.7.3 South America TYK2 Targeting Drugs Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa TYK2 Targeting Drugs Market Facts & Figures by Country
- 5.8.1 Middle East and Africa TYK2 Targeting Drugs Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa TYK2 Targeting Drugs Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa TYK2 Targeting Drugs Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global TYK2 Targeting Drugs Sales by Type (2021-2032)
- 6.1.1 Global TYK2 Targeting Drugs Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global TYK2 Targeting Drugs Sales Market Share by Type (2021-2032)
- 6.2 Global TYK2 Targeting Drugs Revenue by Type (2021-2032)
- 6.2.1 Global TYK2 Targeting Drugs Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global TYK2 Targeting Drugs Revenue Market Share by Type (2021-2032)
- 6.3 Global TYK2 Targeting Drugs Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global TYK2 Targeting Drugs Sales by Application (2021-2032)
- 7.1.1 Global TYK2 Targeting Drugs Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global TYK2 Targeting Drugs Sales Market Share by Application (2021-2032)
- 7.2 Global TYK2 Targeting Drugs Revenue by Application (2021-2032)
- 7.2.1 Global TYK2 Targeting Drugs Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global TYK2 Targeting Drugs Revenue Market Share by Application (2021-2032)
- 7.3 Global TYK2 Targeting Drugs Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 TYK2 Targeting Drugs Value Chain Analysis
- 8.1.1 TYK2 Targeting Drugs Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 TYK2 Targeting Drugs Production Mode & Process
- 8.2 TYK2 Targeting Drugs Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 TYK2 Targeting Drugs Distributors
- 8.2.3 TYK2 Targeting Drugs Customers
9 Global TYK2 Targeting Drugs Analyzing Market Dynamics
- 9.1 TYK2 Targeting Drugs Industry Trends
- 9.2 TYK2 Targeting Drugs Industry Drivers
- 9.3 TYK2 Targeting Drugs Industry Opportunities and Challenges
- 9.4 TYK2 Targeting Drugs Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst